Current Market Review

Well it has certainly been a very unusual and eventful past six months! Given the virus, our in person meetings have been more limited over the past year.

Health Canada approved the Oxford University Astra Zeneca vaccine for use in the fight against COVID-19. Millions of Canadians are expecting to be inoculated in the coming months. In the U.S., the House of Representatives passed Biden’s US $1.9 trillion ‘relief ‘ bill. They estimate that about 9% of this will go to the American people (the rest to special interests, payoffs etc.) It now heads to the Senate for final approval.  Nevertheless, some should trickle into the economy.

We have experienced some volatility over the last month in the markets but there were some slight gains. In the U.S., the S&P 500 Index ended February slightly higher than where it started. In Canada, the S&P TSX Index started the month of February strong and ended slightly up from its starting point. The MSCI World Index, which reflects returns for developed equity markets around the globe, ended flat on the month.

Our market indicators remain up (see Market Trend chart) in this the ‘good season’ and so we should remain invested in a broadly-diversified portfolio based on our risk tolerance. In uncertain times, it is important to stay focused on our long-term goals and stay invested.

As always, should you have any questions regarding your portfolio, please do not hesitate to contact my office.


Market Trend

(click to enlarge)


Ultimate Funds

(click to enlarge)